Crossmark

Glycemic dysregulation in a patient with type 2 diabetes treated with 5-azacitidine: a case report

Crossref DOI link: https://doi.org/10.1186/s13256-018-1690-3

Published Online: 2018-07-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ponard, Antoine https://orcid.org/0000-0002-9199-3225
Ferreira-Maldent, Nicole

Ertault, Marjan

Delain, Martine

Amraoui, Kamel

Regina, Sandra

Jonville-Béra, Annie-Pierre

Hérault, Olivier

Colombat, Philippe

Gyan, Emmanuel
License Information

Text and Data Mining valid from 2018-07-03
More Information

Article History

Received: 29 October 2017

Accepted: 13 April 2018

First Online: 3 July 2018

Consent for publication

: The written informed consent we have in the patient’s file has already been approved by a central review Board. Written informed consent was obtained from the patient’s next-of-kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: Emmanuel Gyan has received research funding and travel grants from Celgene, Corp. All other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.